The effect of metformin treatment on volumes of free-living physical activity and sedentary behaviour: A post-hoc analysis of the PRE-D trial-Reference-Cited by-同舟云学术

The effect of metformin treatment on volumes of free-living physical activity and sedentary behaviour: A post-hoc analysis of the PRE-D trial

Published:2023-09-17 Issue:18 Volume:41 Page:1687-1691
ISSN:0264-0414
Container-title:Journal of Sports Sciences
language:en
Short-container-title:Journal of Sports Sciences

Author:

Karstoft Kristian¹²^ORCID,Ried-Larsen Mathias¹³^ORCID,Bruhn Lea⁴^ORCID,Pilmark Nanna Skytt¹^ORCID,Hansen Katrine Bagge⁴^ORCID,Persson Frederik⁴^ORCID,Jørgensen Marit Eika⁴⁵^ORCID,Blond Martin Bæk⁴^ORCID,Færch Kristine⁴⁶^ORCID

Affiliation:

1. Centre for Physical Activity Research (CFAS), Rigshospitalet, University of Copenhagen, Copenhagen, Denmark

2. Department of Clinical Pharmacology, Bispebjerg-Frederiksberg Hospital, University of Copenhagen, Copenhagen, Denmark

3. Department of Sports Science and Clinical Biomechanics, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark

4. Department of Clinical Research, Steno Diabetes Center Copenhagen (SDCC), Copenhagen, Denmark

5. Steno Diabetes Center Greenland (SDCG), Nuuk, Greenland

6. Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark

Funder

Novo Nordisk

AstraZeneca

Publisher

Informa UK Limited

Subject

Physical Therapy, Sports Therapy and Rehabilitation,Orthopedics and Sports Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/02640414.2023.2291737

Reference15 articles.

1. 8. Pharmacologic Approaches to Glycemic Treatment

2. The association of intensity and overall level of physical activity energy expenditure with a marker of insulin resistance

3. No effects of dapagliflozin, metformin or exercise on plasma glucagon concentrations in individuals with prediabetes: A post hoc analysis from the randomized controlled PRE‐D trial

4. Effect of metformin on exercise capacity: A meta-analysis

5. Protocol for a randomised controlled trial of the effect of dapagliflozin, metformin and exercise on glycaemic variability, body composition and cardiovascular risk in prediabetes (the PRE-D Trial)